Connor, Clark & Lunn Investment Management Ltd. Applied Therapeutics Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.77 - $1.8 $11,014 - $25,747	14,304 New	14,304 $18,000
Q2 2022 Aug 05, 2022	SELL	$0.76 - $2.64 $19,011 - $66,039	-25,015 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.48 - $6.22 $37,022 - $155,593	25,015 New	25,015 $53,000

Others Institutions Holding APLT

# of Institutions

139

Shares Held

111M

Call Options Held

1.68M

Put Options Held

1.91M

Janus Henderson Group PLC London, X0

10.5M
Shares

$6.22 Million
0.05% of portfolio
Morgan Stanley New York, NY

9.9M
Shares

$5.84 Million
0.01% of portfolio
Vr Adviser, LLC New York, NY

9.83M
Shares

$5.8 Million
8.65% of portfolio
Perceptive Advisors LLC New York, NY

8.01M
Shares

$4.72 Million
1.78% of portfolio
Franklin Resources Inc San Mateo, CA

6.8M
Shares

$4.01 Million
0.02% of portfolio

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $28.3M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account